238 related articles for article (PubMed ID: 24681093)
21. [Signal pathways of cell proliferation and death as targets of potential chemotherapeutics].
Repický A; Jantová S; Milata V
Ceska Slov Farm; 2008 Jan; 57(1):4-10. PubMed ID: 18383917
[TBL] [Abstract][Full Text] [Related]
22. Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies.
Reyjal J; Cormier K; Turcotte S
Adv Exp Med Biol; 2014; 772():167-88. PubMed ID: 24272359
[TBL] [Abstract][Full Text] [Related]
23. Autophagy and cancer therapy.
Kondo Y; Kondo S
Autophagy; 2006; 2(2):85-90. PubMed ID: 16874083
[TBL] [Abstract][Full Text] [Related]
24. Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies.
Bincoletto C; Bechara A; Pereira GJ; Santos CP; Antunes F; Peixoto da-Silva J; Muler M; Gigli RD; Monteforte PT; Hirata H; Jurkiewicz A; Smaili SS
Chem Biol Interact; 2013 Nov; 206(2):279-88. PubMed ID: 24121004
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis signaling in tumor therapy.
Fulda S; Debatin KM
Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
[TBL] [Abstract][Full Text] [Related]
26. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
27. Autophagy as a mediator of chemotherapy-induced cell death in cancer.
Notte A; Leclere L; Michiels C
Biochem Pharmacol; 2011 Sep; 82(5):427-34. PubMed ID: 21704023
[TBL] [Abstract][Full Text] [Related]
28. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells.
Kim Y; Jeong IG; You D; Song SH; Suh N; Jang SW; Kim S; Hwang JJ; Kim CS
Anticancer Drugs; 2014 Jan; 25(1):53-62. PubMed ID: 24100277
[TBL] [Abstract][Full Text] [Related]
29. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis-modulating drugs for improved cancer therapy.
Ocker M; Höpfner M
Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
[TBL] [Abstract][Full Text] [Related]
31. Autophagy: an adaptable modifier of tumourigenesis.
Wilkinson S; Ryan KM
Curr Opin Genet Dev; 2010 Feb; 20(1):57-64. PubMed ID: 20080398
[TBL] [Abstract][Full Text] [Related]
32. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy.
Pennington JD; Wang TJ; Nguyen P; Sun L; Bisht K; Smart D; Gius D
Drug Resist Updat; 2005 Oct; 8(5):322-30. PubMed ID: 16230045
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
34. Exploiting death receptor signaling pathways for tumor therapy.
Fulda S; Debatin KM
Biochim Biophys Acta; 2004 Dec; 1705(1):27-41. PubMed ID: 15585171
[TBL] [Abstract][Full Text] [Related]
35. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
36. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic exploitation of necroptosis for cancer therapy.
Fulda S
Semin Cell Dev Biol; 2014 Nov; 35():51-6. PubMed ID: 25065969
[TBL] [Abstract][Full Text] [Related]
38. The autophagic paradox in cancer therapy.
Wu WK; Coffelt SB; Cho CH; Wang XJ; Lee CW; Chan FK; Yu J; Sung JJ
Oncogene; 2012 Feb; 31(8):939-53. PubMed ID: 21765470
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress in apoptosis and cancer: an update.
Matés JM; Segura JA; Alonso FJ; Márquez J
Arch Toxicol; 2012 Nov; 86(11):1649-65. PubMed ID: 22811024
[TBL] [Abstract][Full Text] [Related]
40. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.
Ouyang L; Shi Z; Zhao S; Wang FT; Zhou TT; Liu B; Bao JK
Cell Prolif; 2012 Dec; 45(6):487-98. PubMed ID: 23030059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
